secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0000313143-22-000050
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics reports Q1 FY2023 earnings; no financial details in filing excerpt
------------------------------------------------------------------------------

- Press release dated August 10, 2022, covering quarter ended July 2, 2022, was furnished as exhibit.
- No specific revenue, EPS, or segment data are available from the provided filing text.
- Registrant is Haemonetics Corporation (HAE), a Massachusetts corporation trading on NYSE.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000050/0000313143-22-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000050/hae-20220810.htm
  HTML page:      https://secwatch.observer/filing/0000313143-22-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer